Picture of Johnson & Johnson logo

JNJ — Johnson & Johnson Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

Annual cashflow statement for Johnson & Johnson, fiscal year end - December 28th, USD millions except per share, conversion factor applied.

2022
January 2nd
2023
January 1st
2023
December 31st
2024
December 29th
2025
December 28th
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line20,87817,94135,15314,06626,804
Depreciation
Deferred Taxes
Non-Cash Items1,4591,957-18,1613,2071,403
Unusual Items
Purchased R&D
Other Non-Cash Items
Changes in Working Capital-4,238-4,0112,5071,837-12,718
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities23,41021,19422,79124,26624,530
Capital Expenditures-3,652-4,009-4,543-4,424-4,832
Purchase of Fixed Assets
Other Investing Cash Flow Items-5,031-8,3625,421-14,175-18,756
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-8,683-12,371878-18,599-23,588
Financing Cash Flow Items39565-1,602-736-260
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-14,047-8,871-15,825-3,132-5,539
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash502-3607,7322,246-4,396